Ascendis Pharma A/S (ASND) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

ASND is expected to report earnings to fall 34.78% to -150 cents per share on August 29

Ascendis Pharma A/S ASND Stock Earnings Reports

Q2'24

Est.

$-1.50

Q1'24

Missed

by $0.82

Q4'23

Beat

by $0.37

Q3'23

Missed

by $0.48

Q2'23

Beat

by $0.37

The last earnings report on May 02 showed earnings per share of -229 cents, missing the estimate of -148 cents. With 516.85K shares outstanding, the current market capitalization sits at 8.63B.

View a ticker or compare two or three

Compare

ASND

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ASND
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ASND (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of drug candidates

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

Tuborg Boulevard 12

Phone

+45 70222244

Employees

879

Web

https://www.ascendispharma.com